longterm objectives understand morphogenesis physiological functions coronary blood vessels controlled molecular level contribute translation findings novel effective therapeutics number heart diseases normal morphogenesis physiological functions coronary vessels critically required physiological functions heart therefore may possible treat diseased heart conditions restoring normal morphogenesis physiological functions coronary vessels specific aims proposal 1 test hypothesis angiopoietin1 alone angiopoietin1 vegf effectively enhance coronary angiogenesis result bring functional benefit cardiac adaptation response surgically induced coronary vessel occlusion 2 test hypothesis deficiency anti angiogenic factor angiopoietin2 leads enhanced coronary angiogenesis cardiac adaptation response surgically induced coronary vessel occlusion 3 test hypothesis akt intracellular signaling pathway essential andor sufficient angiopoietin1induced endothelial sprouting vessel tubulogenesis three dimensional fibrin gel culture system vitro assay system related vessel morphogenesis vivo 4 test hypothesis coronary endothelial cells express unique set genes essential mature physiological functions coronary vessels accomplish goals extensive use transgenic mice knockout mice sophisticated small animal surgical method quantitative qualitative morphometric analyses stateoftheart noninvasive imaging method unique cell culture system biochemical methods molecular biological methods upon completion able provide comprehensive vivo evaluations degree usefulness angiopoietins downstream signaling pathway components therapeutic angiogenesis immediate impact improvement current strategies therapeutic angiogenesis heart furthermore may provide useful molecular insights novel aspects physiological functions coronary vessels information may potentially future impact enhance maturation physiological functionality vessels goal therapies based angiogenesis alone may fall short